U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    H2AZ1 H2A.Z variant histone 1 [ Homo sapiens (human) ]

    Gene ID: 3015, updated on 17-Jun-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Identification and validation of an H2AZ1-based index model: a novel prognostic tool for hepatocellular carcinoma.

    Identification and validation of an H2AZ1-based index model: a novel prognostic tool for hepatocellular carcinoma.
    Gao J, Lu Q, Zhong J, Li Z, Pan L, Feng C, Tang S, Wang X, Tao Y, Zhou X, Wang Q., Free PMC Article

    02/23/2024
    SENP5 promotes homologous recombination-mediated DNA damage repair in colorectal cancer cells through H2AZ deSUMOylation.

    SENP5 promotes homologous recombination-mediated DNA damage repair in colorectal cancer cells through H2AZ deSUMOylation.
    Liu T, Wang H, Chen Y, Wan Z, Du Z, Shen H, Yu Y, Ma S, Xu Y, Li Z, Yu N, Zhang F, Cao K, Cai J, Zhang W, Gao F, Yang Y., Free PMC Article

    09/11/2023
    MicroRNA-455-3p accelerate malignant progression of tumor by targeting H2AFZ in colorectal cancer.

    MicroRNA-455-3p accelerate malignant progression of tumor by targeting H2AFZ in colorectal cancer.
    Ye L, Fan T, Qin Y, Qiu C, Li L, Dai M, Zhou Y, Chen Y, Jiang Y., Free PMC Article

    03/16/2023
    Interplay Between the Histone Variant H2A.Z and the Epigenome in Pancreatic Cancer.

    Interplay Between the Histone Variant H2A.Z and the Epigenome in Pancreatic Cancer.
    Ávila-López PA, Nuñez-Martínez HN, Peralta-Alvarez CA, Martinez-Calvillo S, Recillas-Targa F, Hernández-Rivas R.

    03/3/2023
    The H2A.Z-KDM1A complex promotes tumorigenesis by localizing in the nucleus to promote SFRP1 promoter methylation in cholangiocarcinoma cells.

    The H2A.Z-KDM1A complex promotes tumorigenesis by localizing in the nucleus to promote SFRP1 promoter methylation in cholangiocarcinoma cells.
    Wang Q, Qi Y, Xiong F, Wang D, Wang B, Chen Y., Free PMC Article

    11/19/2022
    Analysis of histone variant constraint and tissue expression suggests five potential novel human disease genes: H2AFY2, H2AFZ, H2AFY, H2AFV, H1F0.

    Analysis of histone variant constraint and tissue expression suggests five potential novel human disease genes: H2AFY2, H2AFZ, H2AFY, H2AFV, H1F0.
    Lubin E, Bryant L, Aicher J, Li D, Bhoj E.

    08/6/2022
    H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation.

    H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation.
    Li Z, Hu M, Qiu J, Feng J, Zhang R, Wu H, Hu G, Ren J., Free PMC Article

    03/19/2022
    Characterization of Cancer Stem Cell Characteristics and Development of a Prognostic Stemness Index Cell-Related Signature in Oral Squamous Cell Carcinoma.

    Characterization of Cancer Stem Cell Characteristics and Development of a Prognostic Stemness Index Cell-Related Signature in Oral Squamous Cell Carcinoma.
    Feng J, Li Y, Wen N., Free PMC Article

    03/12/2022
    Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z.

    Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z.
    Chen Z, Zhang Y, Guan Q, Zhang H, Luo J, Li J, Wei W, Xu X, Liao L, Wong J, Li J., Free PMC Article

    11/27/2021
    H2A.Z acetylation by lincZNF337-AS1 via KAT5 implicated in the transcriptional misregulation in cancer signaling pathway in hepatocellular carcinoma.

    H2A.Z acetylation by lincZNF337-AS1 via KAT5 implicated in the transcriptional misregulation in cancer signaling pathway in hepatocellular carcinoma.
    Yuan Y, Cao W, Zhou H, Qian H, Wang H., Free PMC Article

    11/6/2021
    Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma.

    Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma.
    Berta DG, Kuisma H, Välimäki N, Räisänen M, Jäntti M, Pasanen A, Karhu A, Kaukomaa J, Taira A, Cajuso T, Nieminen S, Penttinen RM, Ahonen S, Lehtonen R, Mehine M, Vahteristo P, Jalkanen J, Sahu B, Ravantti J, Mäkinen N, Rajamäki K, Palin K, Taipale J, Heikinheimo O, Bützow R, Kaasinen E, Aaltonen LA.

    10/30/2021
    The N-terminal and C-terminal halves of histone H2A.Z independently function in nucleosome positioning and stability.

    The N-terminal and C-terminal halves of histone H2A.Z independently function in nucleosome positioning and stability.
    Sato S, Tanaka N, Arimura Y, Kujirai T, Kurumizaka H., Free PMC Article

    07/3/2021
    Structural basis of nucleosome dynamics modulation by histone variants H2A.B and H2A.Z.2.2.

    Structural basis of nucleosome dynamics modulation by histone variants H2A.B and H2A.Z.2.2.
    Zhou M, Dai L, Li C, Shi L, Huang Y, Guo Z, Wu F, Zhu P, Zhou Z., Free PMC Article

    06/26/2021
    Multiple roles of H2A.Z in regulating promoter chromatin architecture in human cells.

    Multiple roles of H2A.Z in regulating promoter chromatin architecture in human cells.
    Cole L, Kurscheid S, Nekrasov M, Domaschenz R, Vera DL, Dennis JH, Tremethick DJ., Free PMC Article

    05/29/2021
    Integrated analysis of H2A.Z isoforms function reveals a complex interplay in gene regulation.

    Integrated analysis of H2A.Z isoforms function reveals a complex interplay in gene regulation.
    Lamaa A, Humbert J, Aguirrebengoa M, Cheng X, Nicolas E, Côté J, Trouche D., Free PMC Article

    04/13/2021
    VPS72/YL1-Mediated H2A.Z Deposition Is Required for Nuclear Reassembly after Mitosis.

    VPS72/YL1-Mediated H2A.Z Deposition Is Required for Nuclear Reassembly after Mitosis.
    Moreno-Andrés D, Yokoyama H, Scheufen A, Holzer G, Lue H, Schellhaus AK, Weberruss M, Takagi M, Antonin W., Free PMC Article

    03/6/2021
    these results illuminate the mechanism underlying a human syndrome and uncover selective functions of H2A.Z subtypes during development.

    Single Amino Acid Change Underlies Distinct Roles of H2A.Z Subtypes in Human Syndrome.
    Greenberg RS, Long HK, Swigut T, Wysocka J., Free PMC Article

    06/20/2020
    results suggest that the histone variant H2A.Z epigenetically regulates the licensing and activation of early replication origins and maintains replication timing through the SUV420H1-H4K20me2-ORC1 axis

    H2A.Z facilitates licensing and activation of early replication origins.
    Long H, Zhang L, Lv M, Wen Z, Zhang W, Chen X, Zhang P, Li T, Chang L, Jin C, Wu G, Wang X, Yang F, Pei J, Chen P, Margueron R, Deng H, Zhu M, Li G.

    05/9/2020
    Conclusively, chromatin immunoprecipitation-deep sequencing, confirmed the predominant association of OGDH and ACAA2 with H2A.Z-occupied transcription start sites and enhancers, the former of which we confirmed is conserved in both mouse and human tissue.

    Oxoglutarate dehydrogenase and acetyl-CoA acyltransferase 2 selectively associate with H2A.Z-occupied promoters and are required for histone modifications.
    Choi S, Pfleger J, Jeon YH, Yang Z, He M, Shin H, Sayed D, Astrof S, Abdellatif M., Free PMC Article

    02/1/2020
    Data show that loading and acetylation of H2A.Z are required to assure tight control of canonical notch receptor (Notch) activation.

    Histone variant H2A.Z deposition and acetylation directs the canonical Notch signaling response.
    Giaimo BD, Ferrante F, Vallejo DM, Hein K, Gutierrez-Perez I, Nist A, Stiewe T, Mittler G, Herold S, Zimmermann T, Bartkuhn M, Schwarz P, Oswald F, Dominguez M, Borggrefe T., Free PMC Article

    08/17/2019
    FBXL10-RNF68-RNF2 ubiquitin ligase complex (FRRUC) is rapidly and transiently recruited to sites of DNA damage in a PARP1- and TIMELESS-dependent manner to promote mono-ubiquitylation of H2A at Lys119.

    PARP1-dependent recruitment of the FBXL10-RNF68-RNF2 ubiquitin ligase to sites of DNA damage controls H2A.Z loading.
    Rona G, Roberti D, Yin Y, Pagan JK, Homer H, Sassani E, Zeke A, Busino L, Rothenberg E, Pagano M., Free PMC Article

    03/30/2019
    H2A.Z associates with epigenetic gene activation in prostate cancer.Acetylated H2A.Z role in activation of newly formed enhancers in prostate cancer.

    Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer.
    Valdés-Mora F, Gould CM, Colino-Sanguino Y, Qu W, Song JZ, Taylor KM, Buske FA, Statham AL, Nair SS, Armstrong NJ, Kench JG, Lee KML, Horvath LG, Qiu M, Ilinykh A, Yeo-Teh NS, Gallego-Ortega D, Stirzaker C, Clark SJ., Free PMC Article

    09/22/2018
    The present study demonstrated that H2A.Z is overexpressed in ICC and expression of H2A.Z correlated with poor prognosis in patients with ICC. H2A.Z regulated cell proliferation in vitro and in vivo via H2A.Z/S-phase kinase-associated protein 2/p27/p21 signaling.

    H2A.Z regulates tumorigenesis, metastasis and sensitivity to cisplatin in intrahepatic cholangiocarcinoma.
    Yang B, Tong R, Liu H, Wu J, Chen D, Xue Z, Ding C, Zhou L, Xie H, Wu J, Zheng S., Free PMC Article

    09/1/2018
    study identifies GAS41 as a histone acetylation reader that promotes histone H2A.Z deposition in non-small cell lung cancer.

    Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer.
    Hsu CC, Shi J, Yuan C, Zhao D, Jiang S, Lyu J, Wang X, Li H, Wen H, Li W, Shi X., Free PMC Article

    06/9/2018
    Two possible modes of pioneering associated with combinations of H2A.Z and p300/CBP at nucleosome-occupied enhancers.

    Two possible modes of pioneering associated with combinations of H2A.Z and p300/CBP at nucleosome-occupied enhancers.
    Cauchy P, Koch F, Andrau JC., Free PMC Article

    02/10/2018
    firstprevious page of 3 nextlast